Beta
296909

Evaluation of the clinicopathological significance of E-Cadherin and Ki 67 immuno-expression in triple negative breast cancer

Article

Last updated: 30 Dec 2024

Subjects

-

Tags

Novel in vitro assessment models

Abstract

Background: Breast cancer is one of the most diverse and well-known diseases. It has various molecular subtypes, clinical behaviors, therapeutic responses, and patient outcomes. The absence of hormonal expression (ER&PR) and the lack of excessive human epidermal growth factor receptor 2 expression are the two characteristics that are often used to identify triple-negative breast cancer (HER2). E-Cadherin is a cell adhesion molecule that inhibits metastasis, invasion, and cell growth. A non-histone nuclear protein called Ki 67 is connected to tissue and cellular proliferation.

Aim of the work: to evaluate the pattern of expression of E-cadherin and Ki 67 in the studied triple-negative breast cancer cases and to find their correlation with various clinicopathological parameters.

Materials & Methods: This study was carried out on 60 cases of triple-negative breast cancer. Immunohistochemical staining using E-cadherin and Ki 67 antibodies was done for all cases to evaluate their pattern of expression.

Results: There was a significant statistical negative relation between E-cadherin expression in TNBC and pleomorphic lobular subtype and axillary lymph node metastasis. Also, there was a significant statistical relation between high Ki 67 index (P value < 0.05) and high-grade histological types of TNBC cases, age groups and cases from lower inner quadrant.

Conclusions: Decreased E-cadherin expression is related to positive nodal metastasis. High tumour grade was substantially correlated with high levels of Ki-67 expression.

DOI

10.21608/jcbr.2023.181487.1287

Keywords

E-Cadherin, Ki 67, triple negative breast cancer, non-histone nuclear protein, Cell Adhesion Molecule

Authors

First Name

Eman

Last Name

Esmail

MiddleName

Basiouny

Affiliation

Faculty of Medicine, Tanta University, Tanta, Egypt. Pathology resident in Tanta Cancer Centre, Tanta, Egypt.

Email

emanbasiouny91@gmail.com

City

-

Orcid

0000-0001-5417-5365

First Name

Mohammed

Last Name

El-rashidy

MiddleName

Ali

Affiliation

Pathology department- Faculty of Medicine &ndash;Tanta University

Email

mohamed.elrashidy@med.tanta.edu.eg

City

Tanta

Orcid

-

First Name

Heba

Last Name

Mashhour

MiddleName

Abd El-hai

Affiliation

Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

Email

hebamashhour@live.com

City

Tanta

Orcid

-

First Name

Hend

Last Name

Abo-Safia

MiddleName

Salah

Affiliation

Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.

Email

hend.abosafeia@med.tanta.edu.eg

City

Tanta

Orcid

-

Volume

7

Article Issue

1

Related Issue

39567

Issue Date

2023-03-01

Receive Date

2022-12-18

Publish Date

2023-03-01

Page Start

55

Page End

67

Print ISSN

3009-6391

Online ISSN

3009-7312

Link

https://jcbr.journals.ekb.eg/article_296909.html

Detail API

https://jcbr.journals.ekb.eg/service?article_code=296909

Order

296,909

Type

Original Article

Type Code

885

Publication Type

Journal

Publication Title

Egyptian Journal of Cancer and Biomedical Research

Publication Link

https://jcbr.journals.ekb.eg/

MainTitle

Evaluation of the clinicopathological significance of E-Cadherin and Ki 67 immuno-expression in triple negative breast cancer

Details

Type

Article

Created At

30 Dec 2024